| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/04/2004 | WO2004018663A1 Hybridization sensing part, sensor chip, and hybridization method |
| 03/04/2004 | WO2004018661A1 Regulation of human esterase-like protein |
| 03/04/2004 | WO2004018660A2 Novel lipases and uses thereof |
| 03/04/2004 | WO2004018639A2 Male sterility restoration as a selectable marker in plant transformation |
| 03/04/2004 | WO2004018635A2 Myxococcus xanthus bacteriophage mx9 transformation and integration system |
| 03/04/2004 | WO2004018630A2 Recombinant double-stranded rna phages and uses thereof |
| 03/04/2004 | WO2004018627A2 Methods for propagating adenovirus and virus produced thereby |
| 03/04/2004 | WO2004018626A2 Abasic site endonuclease assay |
| 03/04/2004 | WO2004018625A2 Ovarian cancer-specific promoter |
| 03/04/2004 | WO2004018624A2 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| 03/04/2004 | WO2004018621A2 Method for determining gene knockout strategies |
| 03/04/2004 | WO2004018620A2 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter |
| 03/04/2004 | WO2004018619A2 P53 binding t cell receptor molecules and uses thereof |
| 03/04/2004 | WO2004018520A1 Chimeric mhc protein and oligomer thereof |
| 03/04/2004 | WO2004018518A1 Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof |
| 03/04/2004 | WO2004018517A2 POLYPEPTIDE HAVING GnSAF ACTIVITY AND SYNTHETIC ANTIBODIES |
| 03/04/2004 | WO2004018516A1 Regulation of human secretin-type gpcr (latrophilin) |
| 03/04/2004 | WO2004018515A2 T-cell epitopes in erythropoietin |
| 03/04/2004 | WO2004018514A1 Polypeptides of nontypeable haemophilus influenzae and corresponding dna fragments |
| 03/04/2004 | WO2004018512A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 03/04/2004 | WO2004018508A1 A protein controlling rice tiller, a gene encoding the protein and a method of manipulating plant tiller or branching using the gene |
| 03/04/2004 | WO2004018506A2 Inducible alphaviral/orip based gene expression system |
| 03/04/2004 | WO2004018502A1 Compounds binding to p-selectin |
| 03/04/2004 | WO2004018500A1 Coded nucleic acid carriers |
| 03/04/2004 | WO2004018494A1 4'-thionucleotide |
| 03/04/2004 | WO2004018385A2 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof |
| 03/04/2004 | WO2004018066A2 Aqueous two-phase systems for particle manipulation and encapsulation within microscopic volumes |
| 03/04/2004 | WO2004017945A1 Nanoparticles for dna administration to a target organ |
| 03/04/2004 | WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | WO2004017910A2 Total synthesis of heparin |
| 03/04/2004 | WO2004017749A2 Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed |
| 03/04/2004 | WO2004017728A2 Methods |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2004005554A3 Antisense modulation of livin expression |
| 03/04/2004 | WO2004001020A3 Methods and means to promote gut absorption |
| 03/04/2004 | WO2003106674A3 Use of repression blocking sequences in methods for enhancing gene expression |
| 03/04/2004 | WO2003106636A3 Novel methods for the delivery of polynucleotides to cells |
| 03/04/2004 | WO2003104476A3 Assay to detect replication competent viruses |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003102578A3 High throughput cellular response assay using microarrays |
| 03/04/2004 | WO2003102019A3 Antisense modulation of sterol regulatory element-binding protein-1 expression |
| 03/04/2004 | WO2003101173A3 Immunomodulatory constructs and their uses |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003097678A3 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum |
| 03/04/2004 | WO2003097091A3 Glucan-based vaccines |
| 03/04/2004 | WO2003095653B1 Promoters having a modified transcription efficiency and derived from methyltrophic yeast |
| 03/04/2004 | WO2003093472A3 Cgrp binding nucleic acids |
| 03/04/2004 | WO2003093468A3 Expression system for large functional proteins |
| 03/04/2004 | WO2003087354A3 Novel purified polypeptides involved in nucleotide transport and metabolism |
| 03/04/2004 | WO2003087312A3 Inhibition of tumor growth via peroxiredoxin 3 |
| 03/04/2004 | WO2003083485A3 Protein for use in hypoxia related conditions |
| 03/04/2004 | WO2003080657A3 Yeast pheromones for the treatment of infectious diseases |
| 03/04/2004 | WO2003074719A3 Amino acid-producing bacteria and a process for preparing l-amino acids |
| 03/04/2004 | WO2003074561A8 A method for treating allergic disease and asthma by recombinant adenovirus-and adeno-associated virus-mediated ifn-ϝ gene |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003072787A3 Method for detection of leptin receptor ligands |
| 03/04/2004 | WO2003070972A9 RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/04/2004 | WO2003070941A3 Method for the identification of tissue-specific regulatory sequences |
| 03/04/2004 | WO2003070901A3 Heat stable mutants of starch biosynthesis enzymes |
| 03/04/2004 | WO2003070896A3 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/04/2004 | WO2003070760A3 Anti-amyloid beta antibodies and their use |
| 03/04/2004 | WO2003070229A3 Use of proteinase inhibitors in the treatment of autoimmune diseases |
| 03/04/2004 | WO2003068912A3 PSEUDOMONAS SYRINGAE HARPINS, HopPtoP AND HopPmaHPTO, AND THEIR USES |
| 03/04/2004 | WO2003065871A3 Methods and compositions for treating hematological disorders |
| 03/04/2004 | WO2003064611A3 Methods for creating recombination products between nucleotide sequences |
| 03/04/2004 | WO2003062455A3 Zinc finger domain recognition code and uses thereof |
| 03/04/2004 | WO2003057174A3 Methods and compositions for protein expression and purification |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003055905A3 Proteins of non typable haemophilus influenzae |
| 03/04/2004 | WO2003054189A3 Methods for the transformation of vegetal plastids |
| 03/04/2004 | WO2003054018A3 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 03/04/2004 | WO2003054006A3 Mutated hiv tat |
| 03/04/2004 | WO2003053342A3 Antisense modulation of cd81 expression |
| 03/04/2004 | WO2003052094A3 Expression vector for the production of annexin v |
| 03/04/2004 | WO2003052072A3 Antisense modulation of estrogen receptor alpha expression |
| 03/04/2004 | WO2003051914A3 Ides, an igg-degrading enzyme of streptococcus pyogenes |
| 03/04/2004 | WO2003051912A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 03/04/2004 | WO2003050254A3 Novel chimeric tnf ligands |
| 03/04/2004 | WO2003047547A3 Prenyltransferase from plants |
| 03/04/2004 | WO2003047527A3 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 03/04/2004 | WO2003045988A3 Method to isolate genes involved in aging |
| 03/04/2004 | WO2003042385A3 Gene silencing using sense dna and antisense rna hybrid constructs |
| 03/04/2004 | WO2003040681A3 Genes coding for metabolic pathway proteins |
| 03/04/2004 | WO2003030623A3 System for manipulating nucleic acids |
| 03/04/2004 | WO2003029485A3 Specific differential display arrays |
| 03/04/2004 | WO2003029399A3 Regulatory sequence for the specific expression in fruit of a gene and the applications thereof |
| 03/04/2004 | WO2003027271A3 Regulation of adenovirus dna packaging by iptg |
| 03/04/2004 | WO2003025189A3 A packaging complementation cell-line for sv-40 vectors |
| 03/04/2004 | WO2003025176A8 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 03/04/2004 | WO2003020970A3 New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
| 03/04/2004 | WO2003018766A9 Self-processing plants and plant parts |
| 03/04/2004 | WO2003017751A3 Combinations of genes for producing seed plants exhibiting modulated reproductive development |
| 03/04/2004 | WO2003016536A3 Plasmids from anaerocellum thermophilum and uses thereof |
| 03/04/2004 | WO2003012108A3 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds |
| 03/04/2004 | WO2003008571A3 Chimeric chains that code for proteins that induce effects directed against viruses |
| 03/04/2004 | WO2003008544A3 Antisense modulation of transforming growth factor-beta 3 expression |
| 03/04/2004 | WO2003006669A3 Efficient methods for assessing and validating candidate protein-based therapeutic molecules encoded by nucleic acid sequences of interest |
| 03/04/2004 | WO2003000854A3 Double fructan beets |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2002103052B1 Amplifiable probe |